Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trial.
health services administration & management
oncology
palliative care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
24 03 2023
24 03 2023
Historique:
medline:
28
3
2023
entrez:
24
3
2023
pubmed:
25
3
2023
Statut:
epublish
Résumé
Palliative care (PC) is a medical specialty focusing on providing relief from the symptoms and stress of serious illnesses such as cancer. Early outpatient specialty PC concurrent with cancer-directed treatment improves quality of life and symptom burden, decreases aggressive end-of-life care and is an evidence-based practice endorsed by national guidelines. However, nearly half of patients with advanced cancer do not receive specialty PC prior to dying. The objective of this study is to test the impact of an oncologist-directed default PC referral orders on rates of PC utilisation and patient quality of life. This single-centre two-arm pragmatic randomised trial randomises four clinician-led pods, caring for approximately 250 patients who meet guideline-based criteria for PC referral, in a 1:1 fashion into a control or intervention arm. Intervention oncologists receive a nudge consisting of an electronic health record message indicating a patient has a default pended order for PC. Intervention oncologists are given an opportunity to opt out of referral to PC. Oncologists in pods randomised to the control arm will receive no intervention beyond usual practice. The primary outcome is completed PC visits within 12 weeks. Secondary outcomes are change in quality of life and absolute quality of life scores between the two arms. This study has been approved by the Institutional Review Board at the University of Pennsylvania. Study results will be disseminated in peer-reviewed journals and scientific conferences using methods that describe the results in ways that key stakeholders can best understand and implement. NCT05365997.
Identifiants
pubmed: 36963789
pii: bmjopen-2022-069468
doi: 10.1136/bmjopen-2022-069468
pmc: PMC10040061
doi:
Banques de données
ClinicalTrials.gov
['NCT05365997']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e069468Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA Oncol. 2015 Sep;1(6):778-84
pubmed: 26203912
PLoS One. 2021 Apr 28;16(4):e0249763
pubmed: 33909658
J Am Geriatr Soc. 2019 Jun;67(6):1226-1233
pubmed: 30830695
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
J Am Geriatr Soc. 2007 Jul;55(7):993-1000
pubmed: 17608870
JAMA Netw Open. 2020 Apr 1;3(4):e201768
pubmed: 32236529
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
J Gen Intern Med. 2019 Sep;34(9):1841-1847
pubmed: 31313110
N Engl J Med. 2013 Dec 12;369(24):2347-51
pubmed: 24328469
Lancet. 2014 May 17;383(9930):1721-30
pubmed: 24559581
J Natl Compr Canc Netw. 2021 Jul 28;19(7):780-788
pubmed: 34340208
BMC Palliat Care. 2020 Nov 23;19(1):175
pubmed: 33228651
Oncologist. 2016 Jul;21(7):895-901
pubmed: 27185614